Pharmaron Beijing Co., Ltd. issued a shareholder notification on 21 May 2026 confirming that three key documents for the forthcoming 2025 Annual General Meeting (AGM)—the Circular, the Notice of Meeting and the Proxy Form—have been published on both the company website (www.pharmaron.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).

The notification applies to H-shareholders who previously elected, or were deemed to have consented, to receive corporate communications electronically. Those unable to access the online files may request printed copies free of charge by submitting a Request Form to the company’s H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Shareholders may alter at any time their preferred method of receiving future corporate communications—choosing between printed English, printed Chinese, bilingual print or web-based versions—by emailing 3759-ecom@vistra.com or by written notice to the registrar.

For further enquiries, Pharmaron has provided a hotline at (852) 2980 1333, operating Monday to Friday, 9:00 a.m. to 5:00 p.m. (Hong Kong time), excluding public holidays.

The notification was released under the authority of Dr. Lou Boliang, Chairman of Pharmaron Beijing Co., Ltd.